Shorla wins FDA approval for leukaemia drug

Clonmel-headquartered Shorla specialises in developing innovative oncology drugs, with a focus on orphan and paediatric cancers.

Related Keywords

Ireland ,Philadelphia ,Pennsylvania ,United States ,Orlaith Ryan ,Sharon Cunningham ,Shorla Pharma ,Drug Administration ,Childhood Cancer Research ,Seroba Life Sciences ,Shorla Oncology ,Nelarabine Injection ,Stephenp Hunger ,Seroba Life ,